# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-26-182036
Filing Date
2026-04-27
Accepted
2026-04-27 16:05:17
Documents
19
Period of Report
2026-06-09

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | mcrb-20260427.htm iXBRL | DEF 14A | 2183068
2 | GRAPHIC | img86546405_0.jpg | GRAPHIC | 190953
3 | GRAPHIC | img86546405_1.jpg | GRAPHIC | 65052
4 | GRAPHIC | img86546405_2.gif | GRAPHIC | 183406
5 | GRAPHIC | img86546405_3.gif | GRAPHIC | 188711
6 | GRAPHIC | img86546405_4.jpg | GRAPHIC | 65052
7 | GRAPHIC | img86546405_5.jpg | GRAPHIC | 318712
8 | GRAPHIC | img86546405_6.jpg | GRAPHIC | 387355
| Complete submission text file | 0001193125-26-182036.txt |  | 6834045

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
9 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | mcrb-20260427.xsd | EX-101.SCH | 21630
22 | EXTRACTED XBRL INSTANCE DOCUMENT | mcrb-20260427_htm.xml | XML | 259215

Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Filer) CIK: 0001609809 (see all company filings)

EIN.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37465 | Film No.: 26900843
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)